profit from every $100 of sales.
$0$100
Synergy CHC
$0.00+0.00% today
-100.0% in 1 year
1-year low $0.001-year high $1.79
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Synergy CHC sold, what it kept, and what it did with the cash.
Sales went from $42.8 million in 2023 to $30.4 million in 2025, with -$12.3 million of profit last year.
SalesProfit
Synergy CHC vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Synergy CHC | No profit yet | ||
 Prestige Consumer Healthcare | 11.5× · Cheap | ||
 Great Elm Group | 5.2× · Cheap | ||
 Accendra Health | No profit yet | ||
 Wellgistics Health | No profit yet |
AI analysis
An AI analyst reads Synergy CHC's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| 43 | 35 | 30 | |
| 32 | 24 | 20 | |
| 11 | 6 | -2 | |
| 11 | 6 | -6 | |
| 6 | 2 | -12 | |
| 0.86 | 0.28 | -1.27 | |
| 75.0% | 67.9% | 66.8% | |
| 25.3% | 16.7% | -5.9% | |
| 14.8% | 6.1% | -40.6% |
Balance sheet
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 12 | 16 | 10 |
| Cash | 1 | 1 | 3 |
| Total debt | 28 | 28 | 27 |
| Total liabilities | 40 | 33 | 33 |
| -27 | -17 | -23 | |
| 7 | 8 | 10 | |
| 2,735.7% | 46.0% | -135.1% | |
| -23.2% | -12.8% | 53.4% |
Cash flow
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| 0 | -5 | -3 | |
| – | – | – | |
| 0 | -5 | -3 | |
| Dividends paid | – | – | – |
| – | – | – | |
| – | 0 | 1 |
Valuation
- –
- 0.7×
- –
- -0.1×
- 0.0×
- –
- –
- -191.7%
- -915.2%
- 0.0%
Profitability
- 66.8%
- -5.9%
- -40.6%
- -20.3%
- -48.8%
- 409.7%
- 83.1%
- -121.4%
- -93.2%
- –
Growth
- −15.7%
- –
- +46.2%
- –
- −42.7%
Financial health
- –
- -1.16
- 263.8%
- -0.3×
- 1.22
- 0.76
- 2.99
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 6%of 963
Bottom 16%of 894
Bottom 6%of 908
What analysts expect
- Average price target
- $5.00
- Range
- $5.00 – $5.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -0.23 | 0.03 | −866.7% |
| Apr 1, 2026 | -1.35 | 0.01 | −13,600.0% |
| Nov 13, 2025 | 0.01 | 0.01 | +0.0% |
| Aug 14, 2025 | 0.17 | 0.08 | +112.5% |
| May 15, 2025 | 0.10 | 0.07 | +42.9% |
| Mar 31, 2025 | 0.01 | 0.10 | −90.0% |
| Dec 6, 2024 | 0.10 | 0.10 | +0.0% |
| Jun 30, 2024 | 0.91 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
29No pass
Benjamin Graham
16No pass
Philip Fisher
43No pass
Peter Lynch
2No pass
Joel Greenblatt
2No pass
Charlie Munger
33No pass
Terry Smith
24No pass
Questions about Synergy CHC
Is Synergy CHC a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Synergy CHC AI analysis
What does Synergy CHC do?
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It is in Medical - Distribution.
Does Synergy CHC pay a dividend?
No. Synergy CHC does not pay a dividend at the moment.
Is Synergy CHC stock halal?
No. Synergy CHC does not pass our halal screen: its debt is 1,989% of its market value, at or above the 33% limit. How we check
How has Synergy CHC stock done over the past year?
Down 100.0% over the past twelve months, to $0.00. It traded between $0.00 and $1.79 and is 100.0% below its high.
Who are Synergy CHC's competitors?
The largest listed companies in the same industry are Prestige Consumer Healthcare, Great Elm Group, Accendra Health and Wellgistics Health. The peers table on this page compares their profit, growth and price with Synergy CHC's.
Prices: daily closes to Nov 6, 2026. Fundamentals: company reports via invest-like data.